Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
14.55
+0.53 (3.78%)
At close: May 12, 2025, 4:00 PM
14.52
-0.03 (-0.21%)
After-hours: May 12, 2025, 5:51 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.47 billion as of May 12, 2025. Its market cap has decreased by -40.94% in one year.
Market Cap
2.47B
Enterprise Value
2.09B
1-Year Change
-40.94%
Ranking
Category
Stock Price
$14.55
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.47B, an increase of 1,887.11%. That is a compound annual growth rate of 66.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |